NIH-funded research Sbir 2 grant

Creating a detailed 3D map of the mouse brain using advanced imaging techniques

Official title: A Highly Multiplexed, Multiomic 3D Mouse Brain Map Using MALDI-IHC

Funded at Ambergen, INC · NIH-10705203 · Data updated 2026-11-12

This study is testing a new imaging technique to create a detailed 3D map of the mouse brain, which could help us better understand how the brain works and how diseases like Alzheimer's affect it.

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionAmbergen, INC
NIH-funded
Lab location1 site (Watertown, United States)
Project startSeptember 15, 2022
Project endAugust 31, 2025
Funding year2023
Award (this year)$910,446
NIH project number5R44MH132196-02
Project IDNIH-10705203 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with neurodegenerative disorders or those interested in the underlying mechanisms of brain function.

Less likely to help

Patients with acute brain injuries or those not affected by neurodegenerative conditions may not benefit from this research.

What this research studies

This research focuses on developing a new imaging technology called MALDI-IHC to create a highly detailed 3D molecular map of the mouse brain. By using innovative mass-tags linked to specific antibodies, the study aims to identify and visualize thousands of biomolecules that are crucial for understanding brain function and diseases. This approach allows for a more comprehensive analysis of the brain's molecular composition compared to traditional imaging methods. The findings could provide valuable insights into neurodegenerative disorders and other brain-related conditions.

Why it matters

Potential benefit: If successful, this research could lead to breakthroughs in understanding brain function and the development of new treatments for neurodegenerative diseases.

How similar studies have gone: Other research has shown success with advanced imaging techniques, but the specific approach of MALDI-IHC is relatively novel and untested in this context.

Where this research is happening

  • Ambergen, INC
    Watertown, United States
    Active

Researchers

  • Principal investigator: Lim, Mark — Ambergen, INC
  • Study coordinator: Lim, Mark

Related research

Other NIH-funded projects on the same topics.

  • Developing advanced technology to analyze antibodies for SARS-CoV-2

    This study is working on a new way to closely examine how your immune system responds to COVID-19, including how vaccines help and what happens with long-COVID, so that doctors can provide better, more personalized care for patients like you.

    NIH research Ambergen, INC · Watertown, United States · NIH-10686794

  • Using advanced imaging techniques to study Alzheimer's disease brain tissue.

    This study is exploring new ways to take detailed pictures of brain tissue affected by Alzheimer's disease to better understand how the disease works, which could lead to better ways to diagnose and treat patients in the future.

    NIH research Ambergen, INC · Watertown, United States · NIH-10684250

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.